Multidisciplinary team management is associated with improved outcomes after surgery for esophageal cancer

Diseases of the Esophagus

Volumn 19, Issue 3, 2006, Pages 164-171

  Stephens, M R ^a   Lewis, Wyn G ^c   Brewster, A E ^b   Lord, I ^a   Blackshaw, G R J C ^a   Hodzovic, I ^a   Thomas, G V ^a   Roberts, S A ^c   Crosby, T D L ^b   Gent, C ^a   Allison, M C ^a   Shute, K ^a  

^a ROYAL GWENT HOSPITAL   (United Kingdom)

^b Velindre NHS Trust   (United Kingdom)

^c UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

Author keywords

Esophageal cancer; Multidisciplinary teams; Surgery

Indexed keywords

CISPLATIN; FLUOROURACIL;

ADULT; AGED; ANESTHESIST; ARTICLE; CANCER CENTER; CANCER PATIENT; CANCER SURVIVAL; CONTROLLED STUDY; ESOPHAGUS CANCER; ESOPHAGUS RESECTION; FEMALE; HUMAN; INTERMETHOD COMPARISON; LAPAROTOMY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MANAGED CARE; MEDICAL SOCIETY; MEDICAL SPECIALIST; MULTIMODALITY CANCER THERAPY; MULTIVARIATE ANALYSIS; NEUTROPENIA; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; STATISTICAL SIGNIFICANCE; SURGEON; SURGICAL MORTALITY; SURVIVAL RATE; SURVIVAL TIME; TEAMWORK; THORACOTOMY; TREATMENT OUTCOME; UNITED KINGDOM; UNITED STATES;

ADENOCARCINOMA; ADULT; ALGORITHMS; CARCINOMA, SQUAMOUS CELL; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATIENT CARE TEAM; PROPORTIONAL HAZARDS MODELS; TREATMENT OUTCOME;

EID: 33646789444     PISSN: 11208694     EISSN: 14422050     Source Type: Journal    
DOI: 10.1111/j.1442-2050.2006.00559.x     Document Type: Article

References (27)

1. CRC (Cancer Research Campaign). Cancer Stats Mortality-UK. London, England: Cancer Research Campaign 1999.
2. Earlam R, Cunham-Melo J R. Oesophageal squamus cell carcinoma: I. A critical review of surgery. Br J Surg 1980; 67: 381-90.
3. Sagar P M, Gauperaa T, Sue-Ling H, McMahon M J, Johnston D. An audit of the treatment of cancer of the esophagus. Gut 1994; 35: 941-5.
4. Pye J K, Crumplim M K, Charles J, Kerwat R, Foster M E, Biffin A. One-year survey of carcinoma of the esophagus and stomach in Wales. Br J Surg 2001; 88: 278-85.
5. NHS Executive. Guidance on Commissioning Cancer Services: Improving Outcome in Upper Gastro-Intestinal Cancer: The Manual. London: Department of Health 2001.
6. Kennedy B J. The unified international gastric cancer staging classification. Scand J Gastroenterol 1987; 22: 11-13.
7. Sobin L H, Wittekind C h, eds UICC TNM Classification of Malignant Tumors, 5th edn. New York: John Wiley and Sons 1997.
8. Altman D G, ed. Practical Statistics for Medical Research. London: Chapman & Hall 1991.
9. Kaplan E L, Meier P. Non-parametric estimation from incomplete observations. J Am Statistics Assoc 1958; 58: 457-81.
10. Orringer M B. Transhiatal oesophagectomy without thoracotomy for carcinoma of the thoracic esophagus. Ann Surg 1984; 200: 282-8.
11. Muller J M, Erasmi H, Stelzner M, Zieren U, Pichlmaier H. Surgical therapy of oesophageal carcinoma. Br J Surg 1990; 77: 845-57.
12. Lerut T, DeLeyn P, Coosemans W, Van Raemdonck D, Scheys I, Le Saffre E. Surgical strategies in esophageal carcinoma with emphasis on radical lymphadenectomy. Ann Surg 1992; 216: 583-90.
13. Heald R J, Moran B J, Ryall R D, Sexton R, MacFarlane J K. Rectal cancer: The Basingstoke experience of total mesorectal excision, 1978-1997. Arch Surg 1998; 133: 894-9.
14. Maruyama K, Okabayashi K, Kinoshita T. Progress in gastric cancer surgery in Japan and its limits of radicality. World J Surg 1987; 11: 418-25.
15. Sue Ling H M, Johnston D, Martin I G et al. Gastric cancer: A curable disease in Britain. BMJ 1993; 307: 591-6.
16. Early Breast Cancer Trialist Collaborative Group. Polychemotherapy for early breast cancer: An overview of randomized trials. Lancet 1998; 352: 930-42.
17. O'Connell M, Mailliard J, Kahn M J et al. Control trials of fluorouracil and low dose leucovorin given for 6 months as postoperative adjuvant therapy for colon cancer. J Clin Oncol 1997; 15: 246-50.
18. MRC Oesophageal Cancer Working Party. Surgical resection with or without pre-operative chemotherapy in oesophageal cancer: A randomized controlled trial. Lancet 2002; 359: 1727-73.
19. Kelsen D P, Ginsberg R, Pajak T et al. Chemotherapy followed by surgery compared with surgery alone for localised oesophageal cancer. N Engl J Med 1998; 339: 1070-984.
20. Walsh T N, Noonan N, Hollywood D, Kelly A, Keeling N, Hennessy T P. A comparison of multimodal therapy and surgery for oesophageal adenocarcinoma. N Engl J Med 1996; 335: 462-7.
21. Urba S, Orringer M, Turrisi A, Iannettoni M, Forastiere A, Stravderman M. Randomized trial of pre-operative chemoradiation versus surgery alone in patients with locoregional oesophageal carcinoma. J Clin Oncol 2001; 19: 305-13.
22. Bosset J F, Gignoux M, Triboulet J P et al. Chemotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus. N Engl J Med 1997; 337: 161-7.
23. Crosby T D, Brewster A E, Borley A et al. Definitive chemoradiation in patients with inoperable oesophageal carcinoma. Br J Cancer 2004; 12: 70-5.
24. Lerut T. The surgeon as a prognostic factor. Ann Surg 2000; 232: 729-32.
25. Gillison E W, Powell J, McConkey C C, Spychal R T. Surgical workload and outcome after resection for carcinoma of the esophagus and cardia. Br J Surg 2002; 89: 344-8.
26. Lewis W G, Edwards P, Barry J D et al. D2 or not D2? The gastrectomy question. Gastric Cancer 2002; 5: 29-34.
27. Edwards P, Blackshaw G, Lewis W G, Barry J D, Allison M C, Jones D R. Prospective comparison of D1 versus modified D2 gastrectomy for carcinoma. Br J Cancer 2004; 90: 1888-92.